I-Ethyl (R)-Nipecotate L-Tartrate CAS 167392-57-6 Assay ≥98.0% Ucoceko oluPhezulu olubonakalayo

Ethyl (R)-Nipecotate L-Tartrate CAS 167392-57-6 Assay ≥98.0% High Purity

Inkcazelo emfutshane:

Igama leKhemikhali: Ethyl (R) -Nipecotate L-Tartrate

Izithethantonye: Ethyl (R) -3-Piperidinecarboxylate L-Tartrate

CAS: 167392-57-6

Imbonakalo: Mhlophe ukuya kuMhlophe-Mhlophe wePowder

Uvavanyo: ≥98.0%

Umgangatho ophezulu, iMveliso yoRhwebo

Inquiry: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ubonelelo lwabavelisi ngoBusulungekileyo obuPhezulu kunye noMgangatho oZinzileyo
Igama leKhemikhali: Ethyl (R) -Nipecotate L-Tartrate
CAS: 167392-57-6
Umgangatho ophezulu, iMveliso yoRhwebo

Iipropati zeMichiza:

Igama leMchiza	I-Ethyl (R)-Nipecotate L-Tartrate
Izithethantonye	I-Ethyl (R) -3-Piperidinecarboxylate L-Tartrate
Inombolo yeCAS	167392-57-6
Inombolo yeCAT	RF-PI273
Ubume beStokhwe	Kwi-Stock, iMveliso yeMveliso ukuya kumakhulu eeKilogram
Ifomula yeemolekyuli	C12H21NO8
Ubunzima beMolekyuli	307.3
Indawo yokunyibilika	157.0 ~ 159.0℃
Imeko yokuthumela ngenqanawa	Ithunyelwe Ngaphantsi Kweqondo Lobushushu Le-Ambient
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Mhlophe ukuya kuMhlophe-Mhlophe wePowder
Isivavanyi	≥98.0%
Ilahleko ekomisweni	≤0.50%
Intsalela kwi-Ignition	≤0.30%
Ukungacoceki Okukodwa	≤0.50%
Iintsimbi ezinzima	≤20ppm
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	AbaPhakathi bamayeza

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, Igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.

Izinto eziluncedo:

FAQ:

Isicelo:

I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi we-Ethyl (R)-Nipecotate L-Tartrate (CAS: 167392-57-6) enomgangatho ophezulu, esetyenziswa ngokubanzi kwi-organic synthesis, i-synthesis ye-pharmaceutical intermediates kunye ne-Active Pharmaceutical Isithako (API) synthesis.